Nalaganje...
Discovery of a Bradykinin B2 Partial Agonist Profile of Raloxifene in a Drug Repurposing Campaign
Covid-19 urges a deeper understanding of the underlying molecular mechanisms involved in illness progression to provide a prompt therapeutical response with an adequate use of available drugs, including drug repurposing. Recently, it was suggested that a dysregulated bradykinin signaling can trigger...
Shranjeno v:
| izdano v: | Int J Mol Sci |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7796052/ https://ncbi.nlm.nih.gov/pubmed/33383825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22010257 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|